海王生物：2025年前三季度净利润约2570万元

Group 1 - The core viewpoint of the article highlights the financial performance of Haiwang Biological for the third quarter of 2025, indicating a significant decline in revenue and net profit compared to the previous year [1] - The company's revenue for the first three quarters of 2025 is approximately 21.513 billion yuan, representing a year-on-year decrease of 12.38% [1] - The net profit attributable to shareholders of the listed company is about 25.7 million yuan, showing a year-on-year decline of 44.39% [1] - The basic earnings per share is reported at 0.0098 yuan, which is a decrease of 44.32% year-on-year [1] Group 2 - As of the report, the market capitalization of Haiwang Biological stands at 6.6 billion yuan [2]